| Summa Health Medical Group | |
|
1493 S Hawkins Ave Ste 130 Akron OH 44320-3416 | |
| (234) 867-6828 | |
| Not Available |
| Full Name | Summa Health Medical Group |
|---|---|
| Speciality | Obstetrics & Gynecology |
| Location | 1493 S Hawkins Ave Ste 130, Akron, Ohio |
| Authorized Official Name and Position | Gina Rood (SR SYSTEMS ANALYST) |
| Authorized Official Contact | 2343125961 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Summa Health Medical Group 525 E Market St Po Box 2090 Akron OH 44304-1619 Ph: (330) 996-8798 | Summa Health Medical Group 1493 S Hawkins Ave Ste 130 Akron OH 44320-3416 Ph: (234) 867-6828 |
| NPI Number | 1043463219 |
|---|---|
| Provider Enumeration Date | 10/31/2008 |
| Last Update Date | 12/17/2020 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043463219 | NPI | - | NPPES |
News Archive
Children who have been abused typically experience more intense emotions than their peers who have not been abused. This is often considered a byproduct of living in volatile, dangerous environments. A recent study published in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) set to find out what happens when these children are taught how to regulate their emotions.
On Monday, September 4 and Tuesday, September 5 at the World Congress of Cardiology, Dr. Christopher Granger presented data stressing the importance of prevention of bleeding as a key objective in treatment of acute coronary syndromes.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in adults with attention deficit/hyperactivity disorder (ADHD). TC-5619 is a novel small molecule that is highly selective for the alpha7 neuronal nicotinic receptor, which Targacept refers to as NNR, and was discovered by Targacept scientists using Targacept's proprietary drug discovery platform known as Pentad (TM).
Genzyme Corporation announced today that the European Commission has granted marketing authorization for Mozobil ® (plerixafor injection), providing a significant new option for patients with the blood cancers lymphoma and multiple myeloma who require an autologous stem cell transplant.
Researchers have investigated the differences between 'classic' myocarditis, COVID-19 induced myocarditis, and vaccine-related myocarditis.
› Verified 9 days ago
International Community Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 985 Gorge Blvd, Akron, OH 44310 Phone: 234-312-3607 | |
Summa Health Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 95 Arch St Ste 175, Akron, OH 44304 Phone: 234-867-7606 | |
Bath Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4125 Medina Rd, #215, Akron, OH 44333 Phone: 330-665-8143 Fax: 330-668-1289 | |
Concentra Akron L.l.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1450 Firestone Parkway, Suite F, Akron, OH 44301 Phone: 330-724-3345 Fax: 330-724-5299 | |
Akron Internal Medicine Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1755 W Market St, Akron, OH 44313 Phone: 330-836-2828 Fax: 330-836-0959 | |
Endocrine Associates Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 444 N Main St, Suite 306, Akron, OH 44310 Phone: 330-379-5048 Fax: 330-253-2829 |